Abstract:Objective:To explore the regulation of group 2 innate lymphoid cells (ILC2) recruitment by interleukin-33 (IL-33) , to examine the effect of ILC2 on macrophages during peritoneal infection in sepsis and to further elucidate the immune regulatory mechanism of peritoneal infection.Methods:Forty healthy 6 to 8 week-old male C57BL/6 wild-type mice, twenty Il-33 -/- mice on a C57BL/6 background, and ten IL-33 receptor ST2 knockout (Il1rl1 -/-) mice were bred and housed in the SPF Medical Animal Center of Zhejiang University and the University of Pittsburgh, USA. Receipts of sham surgery were designated as controls and underwent identical surgical procedures were septic mice. IL-33 protein was administered to rmIL-33 group via an exogenous intraperitoneal injection and the changes of ILC2 and its intracellular cytokine levels in peritoneal lavage fluid were detected by flow cytometry. The effects of IL-9 and IL-13 secreted by ILC2 on phagocytic ability of macrophages were confirmed by in vitro experiments. Statistical analysis was performed with t-test or one-way ANOVA test. Results:Compared with ILC2 before/after IL-33 stimulation, the proportion of ILC2 in Lin-CD45 + cells of abdominal cavity increased [(9.90±0.80) vs. (18.43±0.46) ]and the proportion of ILC2 in abdominal cavity jumped after IL-33 stimulation and the difference was statistically significant ( P<0.001). The number of ILC2 in abdominal cavity was [(5 786.00±289.50) vs. (17 820.00±324.30) ]and the number of ILC2 spiked in abdominal cavity after IL-33 stimulation and the difference was statistically significant ( P<0.001). C57BL/6 wild-type mice had a marked increase of peritoneal ILC2 recruitment as compared with control group at 24 h postoperatively [(20.50±0.59) vs. (10.83±1.01) ]and the difference was statistically significant ( P=0.001). However, ILC2 in peritoneal cavity of Il-33 -/- and Il1rl1 -/- mice showed no change at 24 h postoperatively. Moreover, the proportion of ILC2 in Il-33 -/- mice were significantly increased after IL-33 stimulation compared to non-stimulation group (10.53±0.47 vs. 19.43±0.87, P<0.001) , so as in the CLP induced septic mice (10.13±0.57 vs. 21.37±0.86, P<0.001). The study of cytokine levels secreted by ILC2 recruited from abdominal cavity showed that the levels of IL-9 and IL-13 secreted by ILC2 in abdominal cavity increased markedly at 12 h postoperatively and the contents of IL-9 before/after operation were [(16.53±0.74) vs. (24.67±1.45) ]and the differences were statistically significant ( P= 0.007). The proportions of IL-13 at pre/post-operation were [(15.40±0.87) vs. (29.40±0.95) ]and the differences were statistically significant ( P<0.001) while the contents of IL-4 were [(6.14±0.59) vs. (5.89±1.05) ]and the differences were not statistically significant ( P=0.836). An intraperitoneal injection of recombinant IL-33 protein promoted the recruitment of CD45 +F4/80 + macrophages in peritoneal cavity and the proportions before/after injection were [(52.40±1.70) vs. (72.40±2.02) ]and the difference was statistically significant ( P=0.002). Under the action of IL-9/13 secreted by ILC2, phagocytic ability of macrophages was markedly elevated as compared with control group. Phagocytic ability of macrophages under the action of IL-9 was [(61.27±1.46) vs. (48.30±1.65) ]and phagocytic ability of macrophages under the action of IL-13 was [(61.63±2.03) vs. (48.30±1.65) ]and the difference was statistically significant ( P=0.007). Conclusions:IL-33 promotes ILC2 and macrophage recruitment during peritoneal sepsis. And the recruitment of peritoneal ILC2 depends on IL-33/ST2 signaling pathway. Peritoneal ILC2 derived cytokines IL-9 and IL-13 enhance the phagocytosis of macrophages.

IL-33 regulated group 2 innate lymphoid cells promoted the phagocytosis of peritoneal macrophages during sepsis

Protective Role of Ilc2 in Sepsis-Induced Acute Lung Injury

Effect of Interleukin-36β on Activating Autophagy of CD4+CD25+ Regulatory T Cells and Its Immune Regulation in Sepsis.

Interleukin-38 protects against sepsis by augmenting immunosuppressive activity of CD4+ CD25+ regulatory T cells.

Interleukin‐38 protects against sepsis by augmenting immunosuppressive activity of CD4<sup>+</sup>CD25<sup>+</sup> regulatory T cells

Group 2 innate lymphoid cells protect lung endothelial cells from pyroptosis in sepsis

CXCL13 is Involved in the Lipopolysaccharide-Induced Hyperpermeability of Umbilical Vein Endothelial Cells

Increased Susceptibility of S1PR3-Deficient Mice to Escherichia Coli Sepsis is Associated with an Impaired Bactericidal Activity in Macrophage

Group 2 innate lymphocytes protect the balance between autophagy and apoptosis in cardiomyocytes during sepsis-induced cardiac injury

Effect of interleukin-33 on apoptosis of T lymphocytes in a mouse model of sepsis

The Immunoprotective Activity of Interleukin-33 in Mouse Model of Cecal Ligation and Puncture-Induced Sepsis.

Sphingosine 1-Phosphate Receptor-3 Contributes to Host Defense Against Polymicrobial Sepsis Via Modulating Macrophage Chemotaxis (CAM4P.161)

Sphingosine 1-Phosphate Receptor 2 Signaling Suppresses Macrophage Phagocytosis and Impairs Host Defense Against Sepsis.

IL-33 Attenuates Sepsis by Inhibiting IL-17 Receptor Signaling through Upregulation of SOCS3.

ILC2 Proliferated by IL-33 Stimulation Alleviates Acute Colitis in Rag1-/- Mouse through Promoting M2 Macrophage Polarization

Sphingosine 1-Phosphate Receptor 2 Signaling Suppresses Macrophage Phagocytosis and Impairs Host Defense Against Sepsis (INM3P.416)

ILC2s expanded by exogenous IL-33 regulate CD45+CD11b+F4/80high macrophage polarization to alleviate hepatic ischemia-reperfusion injury

Regulation of IL-8 Production by Complement-Activated Product, C5a, in Vitro and in Vivo During Sepsis.

The Role of IL-33 on LPS-Induced Acute Lung Injury in Mice

Leptospiral Lipopolysaccharide-Induced Expression of Inflammatory Cytokines and Mononuclear-Mac-rophage Infiltration in Viscera of Mice with Leptospira Interrogans Infection

The potential role and regulatory mechanism of IL-33/ST2 axis on T lymphocytes during lipopolysaccharide stimulation or perinatal Listeria infection